Vir Biotechnology, Inc. SC 13G and SC 13G/A reports

Location
1800 Owens Street, Suite 900, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/11/2024, 01:27 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report Feb 13, 2024
SC 13G Report Jan 24, 2024
SC 13G/A Report Jan 23, 2024
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G/A Report Jan 24, 2023
SC 13G Report Sep 8, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 11, 2022
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 10, 2022
SC 13G Report SCHEDULE 13G Feb 10, 2022
SC 13G Report SEC SCHEDULE 13G Feb 16, 2021
SC 13G Report SEC SCHEDULE 13G Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 12, 2021
SC 13G/A Report SC 13G/A Feb 11, 2021
SC 13G/A Report May 7, 2020
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP May 4, 2020
SC 13G Report SC 13G Feb 14, 2020
SC 13G Report SC 13G Feb 14, 2020
SC 13G Report Dec 5, 2019
SC 13G Report SC 13G Oct 25, 2019